Life Technologies reported $101.53M in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Ardelyx USD 466.77M 31.02M Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Cipla INR 373.87B 27.32B Mar/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 106.52M 8.48M Jun/2025
CSL USD 38.45B 425M Dec/2024
Galapagos EUR 3.82B 203.72M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Grifols EUR 21.41B 1.12B Dec/2024
Life Technologies USD 101.53M 4.7M Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
United Therapeutics USD 7.91B 164.1M Jun/2025